mTatt
PrivateLast Round
Grant
Nov 27, 2025
Total Funding Raised
$160,000
Company Overview
mTatt is a health technology company developing an innovative microneedle patch for continuous, non-invasive monitoring of health biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Biotechnology, Sensors
Business Model
B2C
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mTatt Comparables
Compare mTatt with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metyos | 82% | |
| PKvitality | 79% | |
| Biolinq | 78% | |
mTatt Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 27, 2025 | ||||
| Angel | Jul 11, 2025 | ||||
| Grant | Jun 1, 2025 | ||||
| Grant | Mar 1, 2025 |
Key People
Founding team and executive leadership
mTatt Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| V1 Studio | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
$50K grant received from V1 Studio.
mTatt Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about mTatt's valuation, stock price, and market status.